Leukaemia Foundation supports myeloma biomarker breakthrough [Publish Date: 16/03/2018]
Research released by QIMR Berghofer Medical Research Institute today identifying the IL-18 molecule as an important biomarker for myeloma is being hailed an important step by the Leukaemia Foundation.
Myeloma is a blood cancer which affects the body’s plasma cells
A friend can be the best thing in the world [Publish Date: 22/02/2018]
When Earlene’s two-year-old son, Jacob, was diagnosed with a rare blood cancer, it felt like, “A punch in the face. It came from nowhere”.
Earlene and Jacob were far from home – it all happened so fast. One minute they were at home in Blackwater, Queensland. The next they were
Leukaemia Foundation Chairman Joins Shave Crew [Publish Date: 21/02/2018]
“Be bold, go bald!”
That’s the call to action from Leukaemia Foundation Chairman, Beverley Mirolo OAM, as she prepares to lose her locks in this year’s 20th World’s Greatest Shave.
Beverley’s team is strong, with daughter Fiona, granddaughter Stephanie and a number of
Haematologist swims oceans to make a difference [Publish Date: 22/01/2018]
Haematologist Orly Lavee will be taking on a 2km ocean swim and 10km coastal run in the Sydney Morning Herald 2018 Sun Run Cole Classic from February 3-4 to help raise awareness and funds for the Leukaemia Foundation.
One of the oldest sporting events in Australia, the Sun
Growing concern as blood cancer rates continue to rise [Publish Date: 16/01/2018]
The Leukaemia Foundation’s CEO Bill Petch is reminding the nation the number of Australians dying from blood cancer is now DOUBLE those losing their life to melanoma 1, as registrations for the 20th anniversary of World’s Greatest Shave open today.
Every day another
Ibrutinib now cheaper for patients [Publish Date: 09/10/2017]
The Leukaemia Foundation welcomes the Federal Government’s announcement that the cancer medicine, IMBRUVICA® (ibrutinib) will be added to Pharmaceutical Benefits Scheme (PBS) from 1 December 2017.
The latest on CAR T-cell therapy research [Publish Date: 28/06/2017]
A clinical trial will test advancements in chimeric antigen receptor (CAR) T-cell therapy developed in Australia and funded by the Leukaemia Foundation*.
The clinical trial opened in Sydney in August 2017 for people with relapsed B-cell leukaemias and lymphomas, following TGA and ethics approvals.
CAR T-cells are a revolutionary
World-first blood test could provide more effective, less invasive blood cancer treatments [Publish Date: 20/06/2017]
A world-first “liquid biopsy” could soon offer you direct access to a simple blood test to help in the monitoring and management of your blood cancer treatment.
The blood test promises a new era of less invasive, more precise and effective management of your blood cancer, in place of painful
15-year Holden partnership celebrated [Publish Date: 15/06/2017]
A brand new Astra, Trailblazer and Trax were unveiled at the recent joint celebration acknowledging Holden’s 15 years of support for the Leukaemia Foundation’s Patient Transport Program in Victoria, bringing their fleet support from 17 vehicles to 20.
Many of our amazing volunteer drivers, supporters of the service and special
Australians living with MPN step closer to accessing Pegasys treatment [Publish Date: 08/06/2017]
The drug interferon alfa-2a (Pegasys®) was finally listed on the agenda of the Pharmaceutical Benefits Advisory Committee (PBAC) meeting on March 8 and many Australians are awaiting the results of the discussion.
For Nathalie Cook, who was diagnosed with MPN in 2008, this achievement was especially exciting after six years